Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2Breast Neoplasms 2Wounds and Injuries 1Stroke 1Stomach Neoplasms 1Spinal Cord Injuries 1Rectal Neoplasms 1Pain, Postoperative 1Muscular Atrophy 1Muscle Spasticity 1Low Anterior Resection Syndrome 1Hereditary leiomyomatosis and renal cell cancer 1Ganglion Cysts 1Esophageal Neoplasms 1Cluster Headache 1Carcinoma, Renal Cell 1Breast Diseases 1Brain Injuries 1

Interventions

Erlotinib Hydrochloride 1Botulinum Toxins, Type A 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hereditary leiomyomatosis and renal cell cancer × Botulinum Toxins, Type A × Clear all
NCT00971620 2017-04-07

Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
18 enrolled 22 charts
Genitourinary

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡